Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sunitinib in VHL Disease
NCT01168440Phase 2Completed
- Sponsor
- ARTIC
- Start
- Mar 2010
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sunitinib in von Hippel–Lindau disease (VHL), sponsored by ARTIC. Started Mar 2010; status: completed.
02
Drugs
sunitinib
03
Conditions
von Hippel–Lindau disease (VHL)
Beyond the preview
Go deeper on NCT01168440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01168440.